Dr Fabio Michelet
Senior Scientist (Viral Vectors)
Dr Fabio Michelet joined CellVec in January 2019 as a Cellular Process Scientist. At CellVec, Dr Fabio plays a key role as part of the Research and Development team and focuses on process optimisation for upstream lentiviral vector manufacturing and the engineering of lentiviral vector producer cell lines with enhanced safety and production efficiency.
Prior to joining CellVec, Dr Fabio conducted academic research at Genome Institute of Singapore (GIS, A*STAR) and Singapore Eye Research Institute (SERI) where he successfully developed novel strategies to combine gene and cell therapy to engineer human Induced Pluripotent Stem cells (iPSC) derived retinal tissue. He has over a decade’s experience in molecular biology, genetic engineering, hematopoietic and embryonic stem cell biology, regenerative medicine, tissue engineering, retroviral and lentiviral vector design and production.
Dr Fabio obtained his PhD in Haematology and Oncology at Paris Descartes University (Paris 5) in 2013 and has been focusing on cell and gene therapy techniques throughout his career.